To further address this, we examined NCR3LG1, an established MYC-induced target in melanoma cells, and an MYCN-induced target in neuroblastoma cells [36], but found no significant coexpression (MYCN vs. NCR3LG1 −0.026 p = 0.57; MYC vs. NCR3LG1 0.067 p = 0.15, Table 1). The gene discussed is MYCN; the disease is melanoma.